• Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

U.S. Loses Key Case on Rights to H.I.V.-Prevention Drugs

In an unusual court trial, a federal jury sided with the drug maker Gilead Sciences in a dispute over who came up with the idea of using a daily pill to prevent H.I.V.

Rebecca Robbins
Author: Rebecca Robbins

Written by

Rebecca Robbins

in

Centers for Disease Control and Prevention, Compensation for Damages (Law), Decisions and Verdicts, Drugs (Pharmaceuticals), Gilead Sciences Inc, Health and Human Services Department, Inventions and Patents, Suits and Litigation (Civil)
←Fox Producer Dismisses, for Now, Case Accusing Network of Coercion
How Wall Street Is Preparing for a Debt Ceiling Showdown→

More posts

  • Arizona Files Criminal Charges Against Kalshi, the Prediction Site

  • Netflix CEO Ted Sarandos Won’t Call Meghan Markle Without a Lawyer: Report

  • 15 Unscripted TV Controversies That Were NOT Supposed To Happen On Live TV

  • Amazon CEO sees AWS sales doubling from prior estimate to $600 billion in 2036

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube